Abnormal hair texture

    La Roche-Posay
  • May 2022
  • 5min

Therapeutic classes inducing this adverse event
BRAF inhibitor, Antiangiogenic agent, MEK inhibitor, SMO inhibitor, EGFR inhibitor

  

  • 1/2
  • 2/2
  • placeholder

CTCAE V5.0

Present


SIMPLIFIED GRADING

Present


References


Peuvrel L, Cassecuel J, Bernier C, Quéreux G, Saint-Jean M, Le Moigne M, Frénard C, Khammari A, Dréno B; Supported by GESTIM Nantes group of cutaneous adverse events induced by cancer treatments. TOXICAN: a guide for grading dermatological adverse events of cancer treatments. Support Care Cancer. 2018;26:2871-7.

Browse for more adverse events